Medicine composition for treating obesity of dogs and preparation method of medicine composition

A composition and obesity technology, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problems of high treatment cost, treatment plan, limited medicine, and failure to achieve therapeutic effect, etc., to achieve unlimited Drug residue, low cost and no drug resistance effect

Inactive Publication Date: 2015-09-30
SHANDONG NEW HOPE LIUHE GROUP
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, dog obesity is mainly treated by eating pet weight loss nutrition tablets and weight loss dog food, etc. The treatment options and drugs are limited, and the ideal treatment effect cannot be achieved, and the treatment cost is relatively high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating obesity of dogs and preparation method of medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1 Pharmaceutical composition 1

[0056] An embodiment of the present invention provides a pharmaceutical composition for treating obesity in dogs, which is made of the following raw materials in parts by weight: 10 parts by weight of Gynostemma pentaphyllum, 22 parts by weight of Radix Astragali, 20 parts by weight of Atractylodes macrocephala, and 8 parts by weight of Laojunxu Parts, 17 parts by weight of Poria cocos, 10 parts by weight of Ficus japonica, 21 parts by weight of Angelica sinensis, 12 parts by weight of Cyperus cyperi, 11 parts by weight of Shihua, 12 parts by weight of golden zebra, 8 parts by weight of palm tree root, 10 parts by weight of emblica, 10 parts by weight of emblica, 13 parts by weight, 14 parts by weight of sage, 9 parts by weight of vitex leaves, 13 parts by weight of marmosets, 15 parts by weight of purple golden bull, 13 parts by weight of geranium, 13 parts by weight of licorice, 14 parts by weight of white horse bone, 21 parts b...

Embodiment 2

[0061] Embodiment 2 pharmaceutical composition 2

[0062]An embodiment of the present invention provides a pharmaceutical composition for treating obesity in dogs, which is made of the following raw materials in parts by weight: 10 parts by weight of Gynostemma pentaphyllum, 22 parts by weight of Radix Astragali, 20 parts by weight of Atractylodes macrocephala, and 8 parts by weight of Laojunxu Parts, 17 parts by weight of Poria cocos, 10 parts by weight of Ficus japonica, 21 parts by weight of Angelica sinensis, 12 parts by weight of Cyperus cyperi, 11 parts by weight of Shihua, 12 parts by weight of golden zebra, 8 parts by weight of palm tree root, 10 parts by weight of emblica, 10 parts by weight of emblica, 13 parts by weight, 14 parts by weight of sage, 9 parts by weight of vitex leaves, 13 parts by weight of marmosets, 15 parts by weight of purple golden bull, 13 parts by weight of geranium, 13 parts by weight of licorice, 14 parts by weight of white horse bone, 21 parts...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating obesity of dogs and a preparation method of the medicine composition. The medicine composition comprises the following active pharmaceutical ingredients: gynostemma pentaphylla, astragalus membranaceus, bighead atractylodes rhizome, root of sandhill tylophora, poria cocos, ficus esquiroliana, angelica, rhizoma cyperi, parmelia saxatilis, inula herb, trachycarpus root, emblic, artemisia hedinii, ficus pumila, negundo chastetree leaves, radix adenophorae tracheioidis, ardisia japonica, concretio silicea bambusae, liquorice, serissa serissoides, amomum cardamomum and grassleaf sweelflag rhizome. The medicine composition has the main functions of spleen invigorating, qi replenishing, and phlegm and dampness eliminating, and auxiliary functions of blood circulation activating and blood stasis removing, so that the function of strengthening body resistance to eliminate pathogenic factors can be realized, the treatment course is relatively short, the treatment effect is relatively good, the medicine tolerance and medicine residues are avoided, the cost price is low, and the weights of the dogs suffering from obesity can be greatly and effectively changed within a short time.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a pharmaceutical composition for treating canine obesity and a preparation method thereof. Background technique [0002] Canine obesity refers to the pathological state in which excessive deposition of adipose tissue leads to changes in the body functions of dogs. It is generally believed that obesity is when the body weight exceeds 15% of the ideal body weight; foreign data show that the incidence of dog obesity is generally 24% to 44%. It can be seen that dog obesity is a relatively common nutritional disease. In my country, with the improvement of people's living standards, the daily nutritional and energy intake levels of dogs are also rising, leading to the clinical obesity of dogs is becoming more and more common. There are many factors that lead to the development of obesity, such as breed, genetic factors, age, sex and lifestyle, etc., but the most fundamental reason...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9064A61P3/04
Inventor 李佃场燕磊唐婷婷
Owner SHANDONG NEW HOPE LIUHE GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products